HIV specific humoral immune response in Rio de Janeiro, Brazil. The HEC/Fiocruz AIDS Clinical Research Group

Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas where anti-HIV/AIDS vaccines are to be employed. Anti-HIV-1 humoral immune response is being studied in infected individuals residents in Rio de Janeiro, in distinct cohorts involving recent seroconvertor...

Full description

Saved in:
Bibliographic Details
Published in:Memórias do Instituto Oswaldo Cruz 1998-05, Vol.93 (3), p.391-398
Main Authors: Bongertz, V, Costa, C I, Guimarães, M L, Soares-da-Costa, M F, Grinsztejn, B, Bastos, F I, Pilotto, J H, João Filho, E C, Loureiro, R, Chequer, P, Telles, P R, Galvão-Castro, B, Morgado, M G
Format: Article
Language:English
Subjects:
AIDS/HIV
Antibody Formation - immunology
Antibody Specificity
Brazil
Cohort Studies
Female
Genotype
HIV Antibodies - genetics
HIV Antibodies - immunology
HIV Infections - genetics
HIV Infections - immunology
HIV Infections - transmission
HIV-1 - immunology
Humans
Male
Neutralization Tests
Pregnancy
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Efforts to characterize HIV-1 polymorphism and anti-HIV immune response are being made in areas where anti-HIV/AIDS vaccines are to be employed. Anti-HIV-1 humoral immune response is being studied in infected individuals residents in Rio de Janeiro, in distinct cohorts involving recent seroconvertors, pregnant women or intravenous drug users (IDU). Comparative analyses of specificity of antibody response towards epitopes important for anti-HIV-1 immune response indicate quantitative differences between cohorts, with an exceptionally strong response in IDUs and weakest response in pregnant women. However, a comparative analysis between pregnant women cohorts from Rio de Janeiro and Rio Grande do Sul indicated an even lower response (with exception of the anti-V3-C clade peptide recognition) for the southern cohort. Studies analysing the immune function of the humoral response indicate a quite elevated occurrence of antibodies capable for neutralizing heterologous primary HIV-1 isolates from Rio de Janeiro. Attempts to correlate seroreactivity with HIV-1 neutralization with respect to HIV-1 polymorphism were not very successful: while the Brazilian B clade B " variant could be recognized by binding assays, no significant distinction of HIV-1 clades/variants was observed in viral neutralization assays.
ISSN:0074-0276